Its deletion downregulates k-RAS expression downstream of β-catenin and simultaneously inhibits colon cancer cell proliferation, whereas IGF2BP1 overexpression increases c-MYC and K-RAS expression and promotes colon cancer cell proliferation [40]. The gene discussed is KRAS; the disease is malignant colon neoplasm.